Details for Patent: 6,706,281
✉ Email this page to a colleague
Summary for Patent: 6,706,281
Title: | Melt-extrusion multiparticulates |
Abstract: | A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an optional water-insoluble binder is disclosed. The particles have a length of from about 0.1 to about 12 mm and can be of varying diameters and each unit dose provides a release of therapeutically active agents over at least about 8 hours. Methods of preparing the unit doses as well as extrusion processes and methods of treatment are also disclosed. |
Inventor(s): | Oshlack; Benjamin (New York, NY), Chasin; Mark (Manalapan, NJ), Huang; Hua-Pin (Englewood Cliffs, NJ) |
Assignee: | Euro-Celtique, S.A. (Luxembourg, LU) |
Application Number: | 10/038,867 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Use; Formulation; |
Drugs Protected by US Patent 6,706,281
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,706,281
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 257375 | ⤷ Sign Up | |||
Austria | 356616 | ⤷ Sign Up | |||
Austria | 357909 | ⤷ Sign Up | |||
Austria | 397441 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |